ANTIVIRAL IL-33-STUMULATED GROUP 2 INNATE LYMPHOID CELLS (CD-90 AND CD-117) FROM MOUSE LUNGS
Main Article Content
Authors
S. Khaidarov
Health Science Center (School of Medicine) of Shenzhen University, 3688 Nanhai Ave, Nanshan District, Shenzhen, China
Abstract
This article represents not only a significant scientific value, but also a great teaching and instruction value for researchers and motivated students to improve the skill spectrum in flow cytometry. This article provides step-by- step procedure description and results based on in vivo studies on murine lung tissue, cell of interest isolation with dual protocols for flow cytometry method as well as IL-33 impact in dynamics. The newly described innate lymphoid cells of group 2 (ILC2) play an important role in type 2 immune reactions, epithelial repair in mucosal tissue and metabolic homeostasis. ILC2 releases large amounts of type 2 cytokines such as interleukin 4 (IL-4), IL-5 and IL-13, which stimulate type 2 immunity, such as protection against worms. However, without strict regulation, the level of ILC2 can cause undesirable type 2 immune pathologies, including allergic inflammation of the respiratory tract, hypersensitivity of the respiratory tract and atopic dermatitis. Viral infections of the respiratory tract, which are typical triggers of type 1 immune reactions, often lead to type 2 pulmonary immune pathologies, such as asthma and its exacerbations. Interestingly, pulmonary virus infections induce the release of IL-33 with subsequent induction of ILC2-mediated type 2 pulmonary immunopathology, which is independent of the adaptive immune system.
Keywords
Innate immunity, Cytokines, Interleukins, IL-33, CD-90, CD117, ILC2
Article Details
References
Hansel TT, Johnston SL, Openshaw PJ Microbes and mucosal immune responses in asthma // Lancet. – 2013.- Vol. 381.-P. 861–873.
Wynn TA Type 2 cytokines: mechanisms and therapeutic strategies. // Nat Rev Immunol. -205.-Vol. 15. -P. 271–282.
Edwards MR, Bartlett NW, Hussell T, Openshaw P, Johnston SL the microbiology of asthma. // Nat Rev Microbiol. -2012.-Vol 10. -P. 459–471
Artis D, Spits H The biology of innate lymphoid cells. // Nature. -2015.-Vol. 517.- P. 293–301.
Paul WE, Zhu J. How are T(H)2-type immune responses initiated and amplified? // Nat Rev Immunol. -2010.-Vol.- 10.- P. 225–235.
Moro K et al. Innate production of T(H)2 cytokines by adipose tissue associated c-kit (+) Sca-1(+) lymphoid cells. // Nature. 2012- Vol. 463. – P. 540–544.
Neill DR et al. Nuocytes represent a new innate effector leukocyte that mediates type- 2 immunity. // Nature. – 2010. -Vol. 464.-P. 1367–1370.
Price AE et al. Systemically dispersed innate IL-13-expressing cells in type 2 immunity. // Proc Natl Acad Sci U S A. -2010.- Vol. 107.-P. 11489–11494.
McKenzie AN, Spits H, Eberl G. Innate lymphoid cells in inflammation and immunity. // Immunity. – 2014.-Vol. 41. P. 366–374.
Diefenbach A, Colonna M, Koyasu S. Development, differentiation, and diversity of innate lymphoid cells. // Immunity. -2014.- Vol.41.-P. 354–365.
Huang Y et al. multipotential ’inflammatory’ type 2 innate IL-25-responsive, lineage-negative KLRG1(hi) cells are lymphoid cells. // Nat Immunol. -2015. – Vol.16.- P. 161–169.